Pradaxa News

Health agency recommends new safety warnings for Pradaxa

June 13th, 2012

The European Medicines Agency (EMA) has recommended that updates be made to the product information packet for the blood-thinning drug Pradaxa. The health agency cited a need for clearer guidance in helping doctors and patients understand the risks of potentially fatal side effects from the drug. More »

Study warns of excess bleeding risk with Pradaxa

April 3rd, 2012

A new study published in the New England Journal of Medicine warns that the lack of an effective treatment for severe bleeding caused by Pradaxa may put the lives of patients taking the drug at risk. The study by researchers at the Haematology Society of Australia and New Zealand examined the cases of dozens of patients who experienced excess bleeding after taking Pradaxa. More »

FDA launches Pradaxa side effects investigation

December 8th, 2011

The Food and Drug Administration has launched an investigation into the anticoagulant Pradaxa after receiving reports of severe bleeding among patients taking the drug. At least 260 deaths caused by excess bleeding have been reported among patients who were using Pradaxa. More »

Pradaxa linked to 260 cases of fatal bleeding

November 12th, 2011

The manufacturer of the anticoagulant drug Pradaxa has reported that at least 260 deaths have been linked to excess bleeding caused by the drug. This new report on the number of Pradaxa deaths was more than five times the previous number of fatalities that had been linked to the drug. More »

I am currently represented by an attorney
*Required fields